Rensselaer Professor Ravi Kane Selected as One of the Top 100 Young Innovators Worldwide
 |
Ravi Kane, the Merck Assistant Professor of Chemical and
Biological Engineering, has been selected as one of the top 100
young innovators in technology from around the world by
Technology Review, Massachusetts Institute of
Technology’s magazine of innovation.
Kane’s primary research focus is on investigating and solving
problems in medicine and biology by the molecular engineering
of materials and surfaces. He works in the areas of
biotechnology, advanced materials, nanotechnology, and
polymers.
Earlier this year Kane was awarded $2.1 million in National
Institutes of Health (NIH) funding to develop an antidote to
counteract the potentially deadly anthrax toxin in humans who
have been exposed to the bacteria’s spores.
Kane is also working to design new molecules that may one day
fend off an HIV infection. In 2003 Kane received a two-year,
$150,000 grant from the National Institute of Allergy and
Infectious Diseases, a division of the National Institutes of
Health, to pursue research into this promising HIV
treatment.
Kane was also among a group of Rensselaer researchers who, in
the March 23, 2004 issue of the Proceedings of the National
Academy of Sciences, reported the discovery of a simple method
for rapidly creating cellular carbon nanotube structures of
different shapes.
“Professor Kane’s work can and will contribute to the
betterment of lives of tens of thousands of people worldwide,”
said Rensselaer Provost G.P. “Bud” Peterson. “We are extremely
pleased to have Professor Kane selected for this honor and to
have his work recognized in this way.”
The so-called “TR100,” chosen by the editors of Technology
Review and an elite panel of judges, consists of 100
individuals under age 35 whose innovative work in technology
promises to have a profound impact on the world. This year’s
nominees, from 14 countries, are recognized for their
contributions in transforming the nature of technology in
industries such as biotechnology, computing, and
nanotechnology.
“Being chosen for the TR100 has become one of the most
prestigious honors for young innovators around the world,” said
David Rotman, executive editor of Technology Review. “This
year’s winners are pioneering fascinating innovations in the
fields of biomedicine, computing, and nanotechnology, and were
chosen after a rigorous selection and judging process. The
result is an elite group whose visions and inventions will
shape the future of technology.”
The TR100 will be honored Sept. 29 - 30 at Technology
Review’s Emerging Technologies Conference at MIT.
Originally published in the September 20, 2004
issue of Campus.News.
Published
September 20,
2004
|
